# | Title | Journal | Year | Citations |
---|
1 | Understanding the Fundamentals of Perfluorocarbons and Perfluorocarbon Emulsions Relevant toIn VivoOxygen Delivery | Artificial Cells, Blood Substitutes, and Biotechnology | 2005 | 290 |
2 | Medical Application of Microbial Biopolyesters Polyhydroxyalkanoates | Artificial Cells, Blood Substitutes, and Biotechnology | 2009 | 198 |
3 | Perfluorocarbon-based Oxygen Delivery | Artificial Cells, Blood Substitutes, and Biotechnology | 2006 | 189 |
4 | Pharmacokinetics and Side Effects of Perfluorocarbon-Based Blood Substitutes | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 139 |
5 | Exploratory Design in Medical Nanotechnology: A Mechanical Artificial Red Cell | Artificial Cells, Blood Substitutes, and Biotechnology | 1998 | 125 |
6 | Nanomaterials as Matrices for Enzyme Immobilization | Artificial Cells, Blood Substitutes, and Biotechnology | 2011 | 125 |
7 | Generation of Alginate-Poly-L-Lysine-Alginate (APA) Biomicrocapsules: the Relationship Between the Membrane Strength and the Reaction Conditions | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 94 |
8 | Hemoglobin Autooxidation/Oxidation Mechanisms and Methemoglobin Prevention or Reduction Processes in the Bloodstream Literature review and outline of autooxidation reaction | Artificial Cells, Blood Substitutes, and Biotechnology | 1998 | 87 |
9 | Hemoglobin Based Oxygen Carriers: How Much Methemoglobin is too Much? | Artificial Cells, Blood Substitutes, and Biotechnology | 1998 | 84 |
10 | Advances in Novel Drug Delivery Strategies for Breast Cancer Therapy | Artificial Cells, Blood Substitutes, and Biotechnology | 2010 | 84 |
11 | CROSS-LINKED POLYHEMOGLOBIN-SUPEROXIDE DISMUTASE-CATALASE SUPPLIES OXYGEN WITHOUT CAUSING BLOOD BRAIN BARRIER DISRUPTION OR BRAIN EDEMA IN A RAT MODEL OF TRANSIENT GLOBAL BRAIN ISCHEMIA-REPERFUSION | Artificial Cells, Blood Substitutes, and Biotechnology | 2002 | 77 |
12 | Heme and the Vasculature: an Oxidative Hazard that Induces Antioxidant Defenses in the Endothelium | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 76 |
13 | Submicron Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: Preparation and Characterization | Artificial Cells, Blood Substitutes, and Biotechnology | 1996 | 74 |
14 | Encapsulation of Human Islets in Novel Inhomogeneous Alginate-Ca2+/Ba2+Microbeads:In VitroandIn VivoFunction | Artificial Cells, Blood Substitutes, and Biotechnology | 2008 | 74 |
15 | Analysis of Polyethylene‐glycol‐polylactide Nano‐Dimension Artificial Red Blood Cells in Maintaining Systemic Hemoglobin Levels and Prevention of Methemoglobin Formation | Artificial Cells, Blood Substitutes, and Biotechnology | 2003 | 71 |
16 | Review of Hemoglobin-Induced Myocardial Lesions | Artificial Cells, Blood Substitutes, and Biotechnology | 2004 | 71 |
17 | Characterization of Processed Tooth Hydroxyapatite for Potential Biomedical Implant Applications | Artificial Cells, Blood Substitutes, and Biotechnology | 1999 | 70 |
18 | Recent and Future Developments in Modified Hemoglobin and Microencapsulated Hemoglobin as Red Blood Cell Substitutes | Artificial Cells, Blood Substitutes, and Biotechnology | 1997 | 69 |
19 | Encapsulation of Enzymes in Liposomes: High Encapsulation Efficiency and Control of Substrate Permeability | Artificial Cells, Blood Substitutes, and Biotechnology | 2004 | 66 |
20 | An Amperometric Biosensor for Uric Acid Determination Prepared from Uricase Immobilized in Polypyrrole Film | Artificial Cells, Blood Substitutes, and Biotechnology | 2006 | 65 |
21 | The Potential Role of Perfluorochemicals (PFCS) in Diagnostic Imaging | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 64 |
22 | CALCULATIONS OF OXYGEN TRANSPORT BY RED BLOOD CELLS AND HEMOGLOBIN SOLUTIONS IN CAPILLARIES | Artificial Cells, Blood Substitutes, and Biotechnology | 2002 | 61 |
23 | Controlled Release of Endothelial Cell Growth Factor from Chitosan-Albumin Microspheres for Localized Angiogenesis: In Vitro and in Vivo Studies | Artificial Cells, Blood Substitutes, and Biotechnology | 1996 | 60 |
24 | Lyophilized Platelets: Fifty Years in the Making | Artificial Cells, Blood Substitutes, and Biotechnology | 2007 | 60 |
25 | A First Evaluation of the Natural High Molecular Weight Polymeric Lumbricus terrestris Hemoglobin as an Oxygen Carrier | Artificial Cells, Blood Substitutes, and Biotechnology | 1997 | 58 |
26 | Effect of Surfactants on the Characteristics of Fluconazole Niosomes for Enhanced Cutaneous Delivery | Artificial Cells, Blood Substitutes, and Biotechnology | 2011 | 58 |
27 | Use ofOxygent™, A Perfluorochemical-Based Oxygen Carrier, as An Alternative to Intraoperative Blood Transfusion | Artificial Cells, Blood Substitutes, and Biotechnology | 1995 | 56 |
28 | Nitric Oxide Mediates the Hypertensive Response to a Modified Hemoglobin Solution (DCLHBTH) in Rats | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 55 |
29 | Characterization of the Hemodynamic Response to Intravenous Diaspirin Crosslinked Hemoglobin Solution in Rats | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 54 |
30 | Influence of Perflubron Emulsion Particle Size on Blood Half-Life and Febrile Response in Rats | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 54 |
31 | Clinical Results of Perftoran Application: Present and Future | Artificial Cells, Blood Substitutes, and Biotechnology | 2005 | 54 |
32 | In VitroComparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the Facilitation of Oxygen Exchange | Artificial Cells, Blood Substitutes, and Biotechnology | 2009 | 53 |
33 | From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond | Artificial Cells, Blood Substitutes, and Biotechnology | 2012 | 52 |
34 | Potential Use of Collagen-Chitosan-Hyaluronan Tri-Copolymer Scaffold for Cartilage Tissue Engineering | Artificial Cells, Blood Substitutes, and Biotechnology | 2006 | 50 |
35 | Crosslinked Hemoglobin-Superoxide Dismutase-Catalase Scavenges Free Radicals in a Rat Model of Intestinal Ischemia-Reperfusion Injury | Artificial Cells, Blood Substitutes, and Biotechnology | 1997 | 48 |
36 | ROLE OF REDOX POTENTIAL OF HEMOGLOBIN-BASED OXYGEN CARRIERS ON METHEMOGLOBIN REDUCTION BY PLASMA COMPONENTS | Artificial Cells, Blood Substitutes, and Biotechnology | 2002 | 47 |
37 | E. coliK-12 Asparaginase-Based Asparagine Biosensor for Leukemia | Artificial Cells, Blood Substitutes, and Biotechnology | 2007 | 46 |
38 | An Amperomertic Uric Acid Biosensor Based on Immobilization of Uricase onto Polyaniline-multiwalled Carbon Nanotube Composite Film | Artificial Cells, Blood Substitutes, and Biotechnology | 2010 | 46 |
39 | Advances in Pulmonary Delivery of Nanoparticles | Artificial Cells, Blood Substitutes, and Biotechnology | 2012 | 46 |
40 | A New Theory of Enterorecirculation of Amino Acids and its use for Depleting Unwanted Amino Acids Using Oral Enzyme-Artificial Cells, as in Removing Phenylalanine in Phenylketonuria | Artificial Cells, Blood Substitutes, and Biotechnology | 1995 | 45 |
41 | Advanced Fluorocarbon-Based Systems for Oxygen and Drug Delivery, and Diagnosis | Artificial Cells, Blood Substitutes, and Biotechnology | 1997 | 45 |
42 | Binding Mechanism of Heavy Metals Biosorption by Pycnoporus Sanguineus | Artificial Cells, Blood Substitutes, and Biotechnology | 1999 | 44 |
43 | FT-IR of membranes made with alginate/polylysine complexes. Variations with the mannuronic or guluronic content of the polysaccharides | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 43 |
44 | Submicron Biodegradable Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: A Preliminary Report | Artificial Cells, Blood Substitutes, and Biotechnology | 1994 | 43 |
45 | Protein Engineering Strategies for Designing More Stable Hemoglobin-based Blood Substitutes | Artificial Cells, Blood Substitutes, and Biotechnology | 1997 | 43 |
46 | Synthesis, Characterization, Biodegradation, and Drug Delivery Application of Biodegradable Lactic/Glycolic Acid Polymers: Part III. Drug Delivery Application | Artificial Cells, Blood Substitutes, and Biotechnology | 2004 | 43 |
47 | Engineering of Rat Articular Cartilage on Porous Sponges: Effects of TGF-β 1and Microgravity Bioreactor Culture | Artificial Cells, Blood Substitutes, and Biotechnology | 2008 | 42 |
48 | Comparing the Chondrogenic Potential in vivo of Autogeneic Mesenchymal Stem Cells Derived from Different Tissues | Artificial Cells, Blood Substitutes, and Biotechnology | 2011 | 42 |
49 | Decreased Agglutinability of Methoxy-Polyethylene Glycol Attached Red Blood Cells: Significance as a Blood Substitute | Artificial Cells, Blood Substitutes, and Biotechnology | 1996 | 41 |
50 | A Method for Purification and Viral Inactivation of Human Placenta Hemoglobin | Artificial Cells, Blood Substitutes, and Biotechnology | 2006 | 41 |